Role of nanomedicine in reversing drug resistance mediated by ATP binding cassette transporters and P-glycoprotein in melanoma

The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker

(2011) Hisashi Kanemaru et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Arginine-Glycine-Aspartic Acid-Conjugated Dendrimer-Modified Quantum Dots for Targeting and Imaging Melanoma

(2010) Zhiming Li et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in Melanoma

(2010) Carmit Levy et al.   MOLECULAR CELL

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

(2010) Pedro P. Medina et al.   NATURE

MicroRNA-200 Family Members Differentially Regulate Morphological Plasticity and Mode of Melanoma Cell Invasion

(2010) Ilan Elson-Schwab et al.   PLoS One

Novel Role for RGS1 in Melanoma Progression

(2009) Javier Rangel et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

MicroRNA-dependent regulation of cKit in cutaneous melanoma

(2009) O. Igoucheva et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Role of miRNAs in the progression of malignant melanoma

(2009) D W Mueller et al.   BRITISH JOURNAL OF CANCER

Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP

(2009) X. Dong et al.   CANCER RESEARCH

Role of microRNAs in the regulation of drug metabolism and disposition

(2009) Ai-Ming Yu   Expert Opinion on Drug Metabolism & Toxicology

miRNA Expression Profiling in Melanocytes and Melanoma Cell Lines Reveals miRNAs Associated with Formation and Progression of Malignant Melanoma

(2009) Daniel W. Mueller et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

(2008) Charles H. Lawrie et al.   BRITISH JOURNAL OF HAEMATOLOGY

Role of ING4 in human melanoma cell migration, invasion and patient survival

(2008) Jun Li et al.   CARCINOGENESIS

HER3 Is a Determinant for Poor Prognosis in Melanoma

(2008) M. Reschke et al.   CLINICAL CANCER RESEARCH

Combining Nanoliposomal Ceramide with Sorafenib Synergistically Inhibits Melanoma and Breast Cancer Cell Survival to Decrease Tumor Development

(2008) M. A. Tran et al.   CLINICAL CANCER RESEARCH

The genetics of malignant melanoma

(2008) Jesus Lomas   Frontiers in Bioscience-Landmark

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin

(2008) O. Kovalchuk et al.   MOLECULAR CANCER THERAPEUTICS

Endogenous human microRNAs that suppress breast cancer metastasis

(2008) Sohail F. Tavazoie et al.   NATURE